Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD5213 + Pregabalin in Painful Diabetic Neuropathy
NCT01928381Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azd5213 in diabetic neuropathy, sponsored by AstraZeneca. Started Nov 2013; status: completed.
02
Drugs
azd5213
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT01928381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01928381.